University of Worcester Worcester Research and Publications

Gluten-Free Diet Indications, Safety, Quality, Labels, and Challenges

Rostami, K., Bold, Justine, Parry, A. and Johnson, M.W. (2017) Gluten-Free Diet Indications, Safety, Quality, Labels, and Challenges. Nutrients, 9 (8). p. 846. ISSN Online: 2072-6643

Full text not available from this repository. (Request a copy)


A gluten-free diet (GFD) is the safest treatment modality in patient with coeliac disease (CD) and other gluten-related disorders. Contamination and diet compliance are important factors behind persistent symptoms in patients with gluten related-disorders, in particular CD. How much gluten can be tolerated, how safe are the current gluten-free (GF) products, what are the benefits and side effects of GFD? Recent studies published in Nutrients on gluten-free products’ quality, availability, safety, as well as challenges related to a GFD are discussed.

Item Type: Article
Additional Information:

The full-text can be accessed via the Official URL.
This article belongs to the Special Issue "From Ptolemaus to Copernicus: The Evolving System of Gluten-Related Disorders".
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Uncontrolled Discrete Keywords: gluten-free diet, non-coeliac gluten sensitivity, coeliac disease, human nutrition
Subjects: Q Science > Q Science (General)
R Medicine > R Medicine (General)
Divisions: College of Health, Life and Environmental Sciences > School of Allied Health and Community
Related URLs:
Copyright Info: Open access article
Depositing User: Justine Bold
Date Deposited: 12 Nov 2018 14:21
Last Modified: 17 Jun 2020 17:25

Actions (login required)

View Item View Item
Worcester Research and Publications is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.